Login

Alan Beasley, CEO, Hydroponics Company Ltd 00:00:00

Share On Facebook Share On Twitter

OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Clarivate assists clients in finding, safeguarding, and promoting their inventions | JONATHAN GEAR, CEO, Clarivate PLC
00:10:00
Unlocking the Potential of K-RAS Mutations in Cancer Therapy| Mark Erlander, CEO, Cardiff Oncology Inc.
00:10:00
The system is the star The more stars we have in our system the brighter the system burns|Justin Ishbia,Managing Partner,Shore Points Capital
00:00:00
Dr. Ralph Highnam, CEO, Volpara Health Technologies Ltd
00:10:00
RPM started with the foundations necessary to conquer the enterprise approach and the core belief that all systems and information|Richard Mathews,CEO,RPMGlobal Holdings Ltd
00:00:00
Detecting cardiac amyloidosis using AI and the ECG - Martha Grogan, M.D. Cardiologist, Mayo Clinic
00:00:00
Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Contango Ore and Dolly Varden Silver Announce Merger to Create North American Precious Metals Powerhouse|Rick Van Nieuwenhuyse,CEO,Contango Ore
00:10:00
Understanding the U.S. Tax System and Capital Gains
00:10:00
"Peter Brereton, President and CEO of TECSYS Inc.; Palo Alto Networks' CEO Nikesh Arora states that billings is a broken metric in this market."|Peter Brereton, President and CEO of TECSYS Inc
00:10:00
William Dawes Discusses Mkango's Rare Earths Project at One-to-One Conference
00:10:00
Divesh Makan: The Visionary Behind ICONIQ and the Future of AI Investment

© 2017 - Neuhu+